Duration of Exercise Program in Interstitial Lung Diseases.

Not Applicable

Completed

• Conditions: Interstitial Lung Disease
• Interventions: Other: Exercise program

• Registration Number: NCT03302702
• Lead Sponsor: Izmir Katip Celebi University

Brief Summary

We aimed to compare the functional results of the 8th week with the results of the 12th week of the exercise programs applied to the patients with ILD.

Detailed Description

Exercise programs (EP) have been shown to be the effective approach for functional outcomes in interstitial lung diseases (ILD). In many studies, the duration of exercise programs varies between 8-12 weeks. However, the optimal duration of exercise program is still unknown.

We aimed to compare the results of the 8th week with the results of the 12th week of the PR programs applied to the patients with ILD.

A total of 14 patients with ILD referred to our PR unit \[11 idiopathic pulmonary fibrosis, 2 sarcoidosis (stage 3 and 4) and 1 nonspecific interstitial pneumonia\] were included in the study. Pulmonary function test, arterial blood gas analysis, 6- minute walk test, mMRC dyspnea scale, quality of life questionnaires and hospital anxiety depression scale were performed before, at the 8th and 12th weeks after the exercise program applied to the patients twice a week.

Study Timeline

• Study Start: 2014-01
• Primary Completion: 2016-01
• Study Completion: 2016-01
• Status Verified: 2017-10
• Study First Submitted: 2017-10-01
• Study First Submitted QC: 2017-10-01
• Last Update Submitted: 2017-10-01
• Study First Posted: 2017-10-05
• Last Update Posted: 2017-10-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 14

Inclusion Criteria

• Completed the 12 week exercise program
• Diagnosed with ILD

Exclusion Criteria

• Not completed 12 week exercise program

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Exercise program	Exercise program	Treatment group

Primary Outcome Measures

Name	Time	Method
Six minute walk test	6 minute	It was performed in a 30-meter long corridor in accordance with American Thoracic Society criteria

Secondary Outcome Measures

Name	Time	Method
mMRC	5 minutes	It was used for dyspnea that patients felt during their daily activities.
Pulmonary Function Test	20 minutes	It was used for assessment of lung functions
SGRQ	30 minutes	A disease-specific quality of life scale
SF-36 Health Survey	30 minutes	A health related quality of life scale
Hospital Anxiety and Depression Inventory	20 minutes	It was used for assessment of anxiety and depression